Table 4.: Medical treatment at inclusion and at 5 year follow-up (%).

  Women Men
Inclusion 5 Year Follow-Up Inclusion 5 Year Follow-Up
Group 1 Group 2 Group 1 Group 2 Group 1 Group 2 Group 1 Group 2
No Prednisolone/DMARD 19 8 30 14 13 9 28 18
GC no DMARD 15 3 6 4 19 5 7 3
MTX* 26 62 32 39 26 63 33 45
SSZ* 29 18 6 5 32 18 9 6
Other mono* 10 5 10 6 9 2 10 2
Combination* 1 3 10 9 1 2 7 11
Biologics* 0 1 6 23 0 1 6 15

* With or without prednisolone, GC-Glucocorticoids
DMARD; disease modifying anti-rheumatic drug, GC; glucocorticoids, MTX; methotrexate, SSZ; sulphasalazine.